View in EDS

Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18–59 Years.

Saved in:
Bibliographic Details
Title: Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18–59 Years.
Authors: Mayer, Erick F1 (AUTHOR), Falsey, Ann R2 (AUTHOR), Clark, Rebecca3 (AUTHOR), Ferguson, Murdo4 (AUTHOR), Cardona, Jose5 (AUTHOR), She, Fahua1 (AUTHOR), Jones, Barbara1 (AUTHOR), Reuter, Caroline1 (AUTHOR), Collins, Avi1 (AUTHOR), Mannan, Anisha1 (AUTHOR)
Source: Clinical Infectious Diseases. 12/15/2025, Vol. 81 Issue 6, pe708-e716. 9p.
Database: Environment Complete
Description
ISSN:10584838
DOI:10.1093/cid/ciaf292